Microcephaly and hereditary spastic paraplegia panels have been updated with multiple new genes. Learn more at www.asperbio.com/asper-neurogenetics
CNV analysis
Published 12/02/2021All NGS panels in our testing menu now include CNV analysis. Panels for frontotemporal dementia, tuberous sclerosis, microcephaly, and hereditary spastic paraplegia cover the analysis of clinically relevant non-coding variants. Learn more at www.asperbio.com/asper-neurogenetics
2021 Annual Ataxia Conference
Published 09/02/2021Asper Biogene is attending the Annual Ataxia Conference, 10-13 March, organised by the National Ataxia Foundation. The conference will be held online and brings together leading ataxia experts. Do not miss the opportunity to get informed about recent research on ataxias and developments in treatment targets and diagnostics.
Take a close look at our virtual booth and learn about Asper Biogene’s genetic testing options for different types of ataxias. Come as you are: Ataxia unmasked!